Susquehanna International Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Sell |
229,989
-138,946
| -38% | -$3.21M | ﹤0.01% | 1244 |
|
|
2025
Q1 | $9.96M | Buy |
368,935
+339,464
| +1,152% | +$9.17M | ﹤0.01% | 648 |
|
|
2024
Q4 | $1.58M | Sell |
29,471
-26,167
| -47% | -$1.4M | ﹤0.01% | 2293 |
|
|
2024
Q3 | $2.53M | Buy |
55,638
+30,014
| +117% | +$1.36M | ﹤0.01% | 1652 |
|
|
2024
Q2 | $1.07M | Buy |
25,624
+19,471
| +316% | +$816K | ﹤0.01% | 2457 |
|
|
2024
Q1 | $232K | Buy |
+6,153
| New | +$232K | ﹤0.01% | 4515 |
|
|
2023
Q2 | – | Sell |
-12,728
| Closed | -$154K | – | 6084 |
|
|
2023
Q1 | $154K | Buy |
+12,728
| New | +$154K | ﹤0.01% | 5037 |
|